Individualized Exercise Program for Treatment of Fatigue in Patients After Hematologic Stem Cell Transplant (HSCT)

This study has been completed.
Sponsor:
Collaborator:
Alberta Cancer Foundation
Information provided by:
AHS Cancer Control Alberta
ClinicalTrials.gov Identifier:
NCT00156871
First received: September 8, 2005
Last updated: January 18, 2012
Last verified: August 2011
  Purpose

The purpose of this study is to investigate the impact of fatigue in severely affected transplant patients.


Condition Intervention
Fatigue
Behavioral: exercise

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Individualized Exercise Program for Treatment of Fatigue in Patients After Hematologic Stem Cell Transplant

Resource links provided by NLM:


Further study details as provided by AHS Cancer Control Alberta:

Primary Outcome Measures:
  • Fatigue score

Estimated Enrollment: 24
Study Start Date: April 2003
Study Completion Date: December 2005
Detailed Description:

Investigates impact of a monitored program in kinesiology lab at the University of Calgary on fatigue in severely affected transplant patients.

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Severe fatigue post transplant

Exclusion Criteria:

  • Other conditions contributing to fatigue (graft versus host disease)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00156871

Locations
Canada, Alberta
Tom Baker Cancer Centre
Calgary, Alberta, Canada, T2N 4N2
Sponsors and Collaborators
AHS Cancer Control Alberta
Alberta Cancer Foundation
Investigators
Study Director: James Russell AHS Cancer Control Alberta
Principal Investigator: Nicole Colos-Reed, Phd University of Calgary
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00156871     History of Changes
Other Study ID Numbers: 181710-DRD 16, ACF 717905155
Study First Received: September 8, 2005
Last Updated: January 18, 2012
Health Authority: Canada: Health Canada

Keywords provided by AHS Cancer Control Alberta:
transplant
fatigue
exercise
Malignant disease

Additional relevant MeSH terms:
Fatigue
Signs and Symptoms

ClinicalTrials.gov processed this record on July 23, 2014